PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)
PURbonedoughâ„¢ positioned to capture its share of the forecasted total spine market expected to grow from 13.3 billon in 2023 to 19 billion in 2030,...
US Patent Office Grants PUR Biologics’ Breakthrough Patent for Activating Immune Cells
Patent thrusts PUR Biologics into the $200B immunotherapy marketIRVINE, CA / ACCESSWIRE / April 19, 2023 / PUR Biologics, a wholly owned subsidiary of HippoFi...
PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery
IRVINE, CA / ACCESSWIRE / April 6, 2023 / PUR Biologics, a subsidiary of HippoFi, Inc. (OTC PINK:ORHB), is proud to announce the launch of...
Chemical Computing Group and Discngine Join Forces
Chemical Computing Group ULC ("CCG") announced today that it has acquired Discngine SAS ("Discngine"), a company that develops state-of-the-art IT solutions for life sciences research....